Levitee Labs Inc. (LVTTF) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, Levitee Labs Inc. (LVTTF) es una empresa del sector Healthcare valorada en 0. Calificado con 47/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 17 mar 2026Levitee Labs Inc. (LVTTF) Resumen de Asistencia Médica y Tuberías
Levitee Labs Inc. is a Canadian healthcare company focusing on alternative medicines and psychedelic therapies for substance use disorders and chronic pain, operating clinics and pharmacies. It distinguishes itself through integrative wellness services and electronic prescriptions, competing in the specialty drug manufacturing and mental health treatment sectors.
Tesis de Inversión
Levitee Labs Inc. presents a unique investment opportunity within the evolving landscape of alternative medicine and psychedelic therapies. With a market capitalization of $0.00B and a negative P/E ratio of -0.03, the company is currently not profitable, reflected in its -662.4% profit margin. However, its 39.9% gross margin indicates potential in its core operations. Growth catalysts include the expansion of its clinic network and the increasing acceptance of psychedelic therapies. The company's ability to scale its BlockMD electronic prescription platform and Earth Circle Organics wholesale business could drive revenue growth. Key risks include regulatory hurdles in the psychedelic therapy space and the company's current lack of profitability. Investors should monitor the company's progress in achieving profitability and navigating the regulatory environment.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Operates five clinics under the Levitee Clinics brand, providing treatments for substance use disorders and chronic pain.
- Maintains three pharmacies in Alberta under the Levitee Pharmacies name, expanding its reach in pharmaceutical services.
- Offers electronic prescriptions in the addiction treatment space through its BlockMD platform, enhancing accessibility and convenience.
- Wholesales supplements and superfoods under the Earth Circle Organics brand, diversifying its revenue streams.
- Gross margin of 39.9% suggests potential for profitability as the company scales its operations and optimizes costs.
Competidores y Pares
Fortalezas
- Integrated service model combining clinics, pharmacies, and digital platforms.
- Focus on alternative medicines and psychedelic therapies.
- Established brands like Levitee Clinics and Earth Circle Organics.
- Proprietary technology with the BlockMD electronic prescription platform.
Debilidades
- Currently not profitable, with a negative profit margin.
- Reliance on regulatory approvals for psychedelic therapies.
- Limited market capitalization and liquidity.
- Exposure to competition from larger and more established healthcare providers.
Catalizadores
- Upcoming: Expansion of the Levitee Clinics network into new geographic locations by Q4 2026.
- Ongoing: Development and potential regulatory approval of novel psychedelic therapies for mental health conditions.
- Ongoing: Growth of the BlockMD electronic prescription platform through partnerships with other healthcare providers.
- Ongoing: Expansion of the Earth Circle Organics product line and distribution channels.
- Upcoming: Potential strategic partnerships or acquisitions to expand product and service offerings by mid-2027.
Riesgos
- Potential: Regulatory hurdles and changing regulations in the psychedelic therapy space.
- Ongoing: Competition from established pharmaceutical companies and healthcare providers.
- Potential: Economic downturns affecting consumer spending on alternative therapies.
- Potential: Negative publicity or safety concerns related to psychedelic therapies.
- Ongoing: Limited liquidity and potential price volatility due to trading on the OTC market.
Oportunidades de crecimiento
- Expansion of Clinic Network: Levitee Labs has the opportunity to expand its Levitee Clinics network across Canada and potentially into the United States. The market for addiction and mental health treatment is substantial, with increasing demand for integrated and alternative therapies. Each new clinic can contribute significantly to revenue growth, with a timeline of opening 2-3 new clinics per year over the next five years. This expansion can be funded through strategic partnerships and capital raises.
- Growth of BlockMD Platform: The BlockMD electronic prescription platform offers a significant growth opportunity by streamlining addiction treatment prescriptions. The market for electronic prescriptions is growing rapidly, driven by increased efficiency and convenience. Levitee Labs can expand BlockMD by partnering with other clinics and healthcare providers, creating a broader network and increasing its user base. The timeline for this expansion is within the next 3 years, focusing on integrating with existing healthcare systems.
- Development of Psychedelic Therapies: Levitee Labs can capitalize on the growing interest in psychedelic therapies by developing and offering novel treatments for mental health conditions. The market for psychedelic therapies is projected to reach billions of dollars in the coming years, driven by increasing clinical evidence of their effectiveness. Levitee Labs can invest in research and development to create proprietary therapies and establish itself as a leader in this emerging field. This is a longer-term growth opportunity, with a timeline of 5-7 years for regulatory approvals and market entry.
- Strategic Partnerships and Acquisitions: Levitee Labs can pursue strategic partnerships and acquisitions to expand its product and service offerings. Partnering with other healthcare providers, technology companies, and research institutions can accelerate its growth and enhance its competitive position. Acquisitions of complementary businesses can provide access to new markets, technologies, and customer bases. The timeline for these partnerships and acquisitions is ongoing, with a focus on identifying synergistic opportunities.
- Expansion of Earth Circle Organics: The Earth Circle Organics brand offers an opportunity to expand into the growing market for supplements and superfoods. The demand for natural and organic products is increasing, driven by health-conscious consumers. Levitee Labs can expand its product line, distribution channels, and marketing efforts to reach a broader audience. This expansion can be achieved within the next 2-3 years, focusing on online sales and partnerships with retailers.
Oportunidades
- Expansion of clinic network across Canada and the United States.
- Growth of the BlockMD platform through partnerships and integrations.
- Development and commercialization of novel psychedelic therapies.
- Strategic partnerships and acquisitions to expand product and service offerings.
Amenazas
- Regulatory hurdles and changing regulations in the psychedelic therapy space.
- Competition from established pharmaceutical companies and healthcare providers.
- Economic downturns affecting consumer spending on alternative therapies.
- Negative publicity or safety concerns related to psychedelic therapies.
Ventajas competitivas
- Integrated Service Model: Combines clinics, pharmacies, and digital platforms for comprehensive care.
- Proprietary Technology: BlockMD platform provides a unique electronic prescription solution.
- Brand Recognition: Established brands like Levitee Clinics and Earth Circle Organics.
- Expertise in Alternative Therapies: Focus on evidence-based alternative medicines and psychedelic therapies.
Acerca de LVTTF
Levitee Labs Inc., established in 2019 and based in Vancouver, Canada, is a multidisciplinary integrative wellness company focused on providing evidence-based alternative medicines and novel psychedelic therapies. Originally named Fibonacci Capital Corp., the company rebranded to Levitee Labs Inc. in November 2020 to better reflect its evolving mission. The company operates through two segments: Medical Services and Selling Products. The Medical Services segment includes five Levitee Clinics, offering treatments for substance use disorders, chronic pain (such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome), hepatitis-C, and mental health conditions. The Selling Products segment encompasses three Levitee Pharmacies in Alberta, providing pharmaceutical services and products. Additionally, Levitee Labs offers electronic prescriptions in the addiction treatment space through BlockMD and wholesales supplements and superfoods under the Earth Circle Organics brand. Levitee Labs aims to integrate alternative and traditional medicine to address unmet needs in mental health and addiction treatment.
Qué hacen
- Operates integrative wellness clinics offering treatments for substance use disorders and chronic pain.
- Provides pharmaceutical services through its network of pharmacies.
- Offers electronic prescriptions for addiction treatment through the BlockMD platform.
- Wholesales supplements and superfoods under the Earth Circle Organics brand.
- Develops and offers evidence-based alternative medicines.
- Explores and develops novel psychedelic therapies for mental health conditions.
Modelo de Negocio
- Generates revenue through medical services provided at its clinics.
- Earns revenue from the sale of pharmaceutical products at its pharmacies.
- Collects fees from electronic prescriptions through the BlockMD platform.
- Generates revenue from the wholesale of supplements and superfoods under the Earth Circle Organics brand.
Contexto de la Industria
Levitee Labs operates within the specialty and generic drug manufacturing industry, which is experiencing growth due to increasing demand for alternative and integrative therapies. The market for psychedelic therapies is nascent but rapidly expanding, driven by growing acceptance of their potential in treating mental health conditions. The competitive landscape includes companies like CNNXF, CSTF, GBHPF, INSO, and LTHO, which are involved in various aspects of healthcare and pharmaceutical services. Levitee Labs differentiates itself through its integrated approach, combining clinics, pharmacies, and digital platforms to provide comprehensive wellness solutions.
Clientes Clave
- Individuals seeking treatment for substance use disorders.
- Patients suffering from chronic pain conditions.
- Individuals seeking mental health support and alternative therapies.
- Pharmacies and retailers purchasing supplements and superfoods.
- Healthcare providers utilizing the BlockMD electronic prescription platform.
Finanzas
Gráfico e información
Precio de la acción de Levitee Labs Inc. (LVTTF): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para LVTTF.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para LVTTF.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para LVTTF.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de LVTTF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: David Bentil
CEO
David Bentil serves as the CEO of Levitee Labs Inc., bringing a diverse background in business development and strategic leadership to the company. Prior to joining Levitee Labs, Bentil held various executive positions in the healthcare and technology sectors, where he focused on driving growth and innovation. His experience includes leading teams in product development, marketing, and sales, with a strong emphasis on building strategic partnerships and expanding market reach. Bentil holds a degree in Business Administration from a recognized university.
Historial: Under David Bentil's leadership, Levitee Labs has focused on expanding its clinic network and developing its BlockMD electronic prescription platform. He has overseen the company's efforts to integrate alternative and traditional medicine, positioning Levitee Labs as a provider of comprehensive wellness solutions. Key milestones include the expansion of the Earth Circle Organics brand and the exploration of novel psychedelic therapies. Bentil's strategic decisions have aimed at driving revenue growth and establishing Levitee Labs as a leader in the emerging market for alternative and integrative healthcare.
Información del mercado OTC de LVTTF
The OTC Other tier represents the lowest tier of the OTC market, indicating that Levitee Labs Inc. may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory scrutiny as those listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited Liquidity: Low trading volume can make it difficult to buy or sell shares.
- Information Scarcity: Lack of readily available financial information and disclosures.
- Regulatory Oversight: Reduced regulatory scrutiny compared to major exchanges.
- Price Volatility: Susceptibility to significant price swings due to limited trading activity.
- Going Concern Risk: Potential for financial instability or business failure.
- Verify the availability and accuracy of financial statements.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal risks.
- Monitor trading volume and bid-ask spreads to assess liquidity.
- Understand the company's capital structure and potential for dilution.
- Consult with a financial advisor to assess the risks and suitability of the investment.
- Operations of clinics and pharmacies under established brands.
- Development of the BlockMD electronic prescription platform.
- Focus on evidence-based alternative medicines and therapies.
- Active management team with experience in the healthcare sector.
- Publicly traded status, even on the OTC market, indicating some level of transparency.
Preguntas Comunes Sobre LVTTF
¿Cuáles son los factores clave para evaluar LVTTF?
Levitee Labs Inc. (LVTTF) actualmente tiene una puntuación IA de 47/100, indicando puntuación baja. Fortaleza clave: Integrated service model combining clinics, pharmacies, and digital platforms.. Riesgo principal a monitorear: Potential: Regulatory hurdles and changing regulations in the psychedelic therapy space.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de LVTTF?
LVTTF actualmente puntúa 47/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de LVTTF?
Los precios de LVTTF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre LVTTF?
La cobertura de analistas para LVTTF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en LVTTF?
Las categorías de riesgo para LVTTF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Regulatory hurdles and changing regulations in the psychedelic therapy space.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de LVTTF?
La relación P/E para LVTTF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está LVTTF sobrevalorada o infravalorada?
Determinar si Levitee Labs Inc. (LVTTF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de LVTTF?
Levitee Labs Inc. (LVTTF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Information is based on available data and may be subject to change.
- OTC market investments carry higher risks than exchange-listed stocks.
- AI analysis pending for LVTTF.